Blood Pressure Medications Recalled Contain Unacceptable Level of Cancer-Causing Ingredient


Published: October 24, 2021

Health News Briefs

Two blood pressure drugs, irbesartan tablets and irbesartan and hydrochlorothiazide tablets, are being recalled because they contain higher than acceptable levels of the cancer-causing substance, N-nitrosoirbesartan. Lupin Pharmaceuticals issued the recall voluntarily. So far, only four people have reported illness potentially related to the medicine. The first batches of the affected medicine were distributed in October of 2018. Lupin Pharmaceuticals has been contacting pharmacies, supermarkets, and wholesalers to initiate a return of their recalled products. The company says that anyone who is currently taking the medication should contact their doctor for advice on next steps.

Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.

Shop Now

Leave a Comment